Rubella mass campaigns

Current Topics in Microbiology and Immunology

Volumn 304, Issue , 2006, Pages 221-229

  Reef, S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RUBELLA VACCINE;

AFRICA; BLOOD BANK; CONGENITAL RUBELLA SYNDROME; DISEASE PREDISPOSITION; DRUG BIOAVAILABILITY; EUROPEAN AMERICAN; HOST SUSCEPTIBILITY; HUMAN; MASS IMMUNIZATION; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; RUBELLA; SOUTHERN EUROPE; DISEASE TRANSMISSION; IMMUNOLOGY;

RUBELLA;

HUMANS; MASS IMMUNIZATION; RUBELLA; RUBELLA VACCINE;

EID: 34548681829     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-540-36583-4_12     Document Type: Review

References (13)

1. Gregg NM (1941) Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 3:35-46
2. Weller TH, Neva FA (1962) Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc Soc Exp Bio Med 111:215-225
3. Parkman PD, Beuscher EL, Artenstein MS (1962) Recover of rubella virus from army recruits. Proc Soc Exp Bio Med 111:225-230
4. Cooper LZ (1975) Congenital rubella in the United States. In: Krugman S, Gershon A (eds). Symposium on infections of the fetus and newborn infant. Alan R. Liss, New York
5. Centers for Disease Control and Prevention (1969) Prelicensing statement on rubella virus vaccine: Recommendation of the Public Health Service Advisory committee on Immunization Practices. MMWR 18
6. Tobin JO, Sheppard S, Smithells RW, Milton A, Noach N, Reid D (1985) Rubella in the United Kingdom, 1970-1983. Rev Infect Dis 7:S47-S52
7. Irons B, Lewis MJ, Dahl-Regis M, Castillio-Soloranzo Carrasco P, deQuadro C (2000) Strategies to eradicate rubella in the English-speaking Caribbean. Am J Public Health 90:1545-1549
8. Vyse AJ, Gay NJ, White JM, et al. (2002) Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev 24(2):125-136.
9. Castillo-Solorzano C, Carrasco P, Tambini G, et al. (2003) New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis 187 Suppl 1:S146-152.
10. de Quadros CA, Izurieta H, Venczel L, Carrasco P (2003) Measles eradication in the Americas: progress to date. J Infect Dis 189 Suppl 1:S227"235.
11. Hinman AR, Hersh BS, deQuadros C (1998) Rationale use of Rubella vaccine for the prevention of congenital rubella syndrome in the Americas. Rev Panam Salud Publica 4:156-160
12. World Health Organization (2000) Rubella vaccine: WHO position paper. Wky Epidemiol Rec 75(20):161-166.
13. WHO Weekly Epidemiologic Record (2005) Progress towards elimination of measles and prevention of congenital rubella infection in the WHO European Region 1990-2004. WHO WER 80:66-71